New hope for kids with MS: testing Easier-to-Take pills
NCT ID NCT07483632
First seen Mar 25, 2026 · Last updated Apr 17, 2026 · Updated 3 times
Summary
This study aims to test the safety and effectiveness of two oral medications, diroximel fumarate (DRF) and dimethyl fumarate (DMF), for treating children with relapsing forms of multiple sclerosis (MS). It will involve about 185 children and teens, comparing the new pills to an existing MS drug called fingolimod over two years. The main goals are to see which treatment causes fewer side effects and is better at preventing MS relapses and new brain lesions.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for RELAPSING FORMS OF MULTIPLE SCLEROSIS are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Email: •••••@•••••
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Conditions
Explore the condition pages connected to this study.